INSIGHTS ON CLINICAL TRIAL DESIGN
-
Imunon Phase IB Ovarian Cancer Study Shows Strong Progression-Free Survival Treatment Effect Using A Synthetic Control Arm
Explore how Imunon used a control arm among stage III/IV ovarian cancer patients in their clinical trial.
-
Operational Innovations That Enhance Site-Sponsor Collaboration
Overcome obstacles associated with collaboration that, when left unaddressed, lead to site selection and patient enrollment issues for sponsors and operational challenges for sites.
-
Digital Front Door Improves Patient And Clinician Satisfaction
Glean insights from this presentation into how sponsors are amplifying patient access and involvement, while simultaneously mitigating clinician exhaustion.
-
The Ultimate Guide To Clinical Supplies For Japan Studies
Catalent's local team in Japan provides comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, and local and global distribution.
-
When Will Full Adherence To EU (536/2014) Be Required?8/10/2022
In January 2022, EU (536/2014) – a binding regulation across all members of the EU – came into effect. The new regulation will streamline procedures and remove duplication of single submission via a single EU portal. It also focuses on an assessment procedure leading to a single decision, rules on the protection of subjects and informed consent, a greater level of harmonization, and transparency requirements.
-
HIV – Global Clinical Trial Landscape1/3/2024
Get a comprehensive overview of the global HIV clinical trial landscape since 2018, showcasing regional leadership, trial phases, and growth rates.
-
Patient Insights Program: Generating Better Clinical Trial Experiences6/13/2023
Discover how Medidata's Patient Insights Program is working to integrate patient perspectives throughout the software development life cycle to enhance participant experiences in clinical trials.
-
The Past, Present, And Future Of Treating Hematological Cancers6/7/2023
What was once science fiction has moved up to second-line therapy. Read this author's take on navigating the trajectory of how CAR T-Cell Therapy will be used for diffuse large B-cell lymphoma.
-
Study Launches Early Phase In Australia With Later Expansion To China5/8/2023
Understand how a biotech company was able to facilitate clinical development plans to extend its study into China for Phase II component, as quickly as possible.
CLINICAL TRIAL DESIGN SOLUTIONS
-
See how Citeline Connect is expanding sponsors’ reach to the right patients through a marketplace of 100+ recruitment vendors and a network of 1.7 million-plus healthcare professionals through a single platform.
-
By conducting trial visits outside of the site, physicians can expand their reach, making drug development more accessible. Read about how MRN's Home Trial Support "HTS" is the engine powering DCTs.
-
Discover how to seamlessly integrate a broad range of leading industry solutions to create an innovative, patient-centered approach that caters to specific diversity and clinical trial requirements.
-
Advarra’s Budget Setup Service helps your organization manage a large quantity of negotiated budgets, providing resourcing capacity to keep your project moving forward while maintaining financial visibility in your OnCore Enterprise Research System.
-
IQVIA Biotech offers extensive immuno-oncology (IO) expertise that spans across multiple treatment modalities (vaccines, bispecific antibodies, adoptive cell therapies [ACT], etc.) and numerous indications across hematologic malignancies and solid tumors.